Amarex Clinical Research LLC – Trademark Portfolio
Entity Type: 16
Amarex Clinical Research LLC holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include WEBVIEW EDC, WEBVIEW IRT, WEBVIEW CTMS, and WEBVIEW EPRO. The owner is based in Germantown, MD.
20201 Century Blvd.
Floor 4
Germantown, MD 20874
Showing of trademarks Trademarks
Trademark Classifications
Amarex Clinical Research LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Amarex Clinical Research LLC have?
Amarex Clinical Research LLC has 14 U.S. trademarks filed with the USPTO. Of these, 4 registered, 10 abandoned.
What trademark classes does Amarex Clinical Research LLC file in?
Amarex Clinical Research LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Amarex Clinical Research LLC's most well-known trademarks?
Amarex Clinical Research LLC's registered trademark portfolio includes well-known marks such as WEBVIEW EDC, WEBVIEW IRT, WEBVIEW CTMS, and WEBVIEW EPRO. These are among 4 currently registered trademarks in the portfolio.
What is Amarex Clinical Research LLC's trademark registration success rate?
Amarex Clinical Research LLC has a 29% trademark registration rate, with 4 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.